TIDMAIA
ALTIN market review and portfolio holdings as of 1st July
2015
Baar, 16 July 2015 - ALTIN AG (SIX: ALTN, LSE: AIA), the Swiss
alternative investment company listed on the London and Swiss stock
exchanges, today discloses its entire hedge fund portfolio holdings
as part of its policy of full transparency to investors. The
portfolio, featuring more than 40 underlying hedge funds, is
particularly well diversified and has a NAV performance of
+219.53%1 since its inception in December 1996.
ALTIN continues to deliver solid outperformance
After the +8.60% share price appreciation in 2014, the positive
share price trend continued in 2015, with ALTIN shares rising by a
further +13.26% during the first half of the year. Over the same
period, the share price discount to NAV has fallen significantly
since the beginning of 2015, reducing from 21.8% to 14.5%. In the
first half of 2015 the NAV is up +3.60% (estimated). Thanks to the
permanent capital base provided by its structure, the ALTIN
portfolio can be allocated to funds that require a slightly longer
lock-up but offer potentially higher returns, without incurring any
liquidity mismatch. The portfolio remains however highly liquid,
with 58.19% of assets invested in funds with monthly or better
liquidity, allowing the manager to make allocation shifts when
deemed necessary.
Portfolio as at 1st July 2015 Total Portfolio (%)
Macro 28.29%
Civic Capital Currency Offshore Fund Ltd 1.84%
Cumulus Fund Leveraged 2.38%
Finisterre Global Opportunity Fund 1.61%
Fortress Macro Fund Ltd 2.58%
Goldfinch Capital Management Offshore Ltd 2.38%
H2O Vivace 3.07%
Quantica Managed Futures Fund Inc 2.91%
Stone Milliner Macro Fd Inc 3.57%
The Tudor BVI Global Fund Ltd 2.89%
Two Sigma Compass Enhanced Cayman Fund Ltd 5.06%
Equity Hedge 21.37%
Arrow Offshore Ltd 2.27%
Clearline Capital Partners Offshore Ltd 3.40%
Coatue Offshore Fund Ltd 3.74%
DB Platinum Ivory Optimal Fund 1.74%
NPJ Global Opportunities Fund 3.33%
Verrazzano European Focus Fund PLC 3.84%
Zeal China Fund Limited 3.05%
Event Driven 30.46%
Aristeia International Ltd 3.78%
Contrarian Emerging Markets Offshore Fund Ltd 3.56%
Jana Nirvana Offshore Fund Ltd 5.38%
LLSOF LP 3.30%
Merrill Lynch Investment Solutions - Castlerigg 1.52%
Equity Event and Arbitrage UCITS Fund
Marathon Special Opportunity Fund Ltd 5.14%
Paulson Enhanced Ltd 3.17%
York European Focus Unit Trust 4.61%
Relative Value 38.77%
Acadian Global Leveraged Market Neutral Equity UCITS 1.83%
Atlas Enhanced Fund Ltd 2.91%
Capstone Vol Offshore Ltd 2.94%
Citadel Kensington Global Strategies Fund Ltd 6.19%
Claren Road Credit Fund Ltd 2.15%
Millennium International 3.87%
Providence MBS Fund Ltd 3.83%
Stratus Feeder Ltd 3.89%
Two Sigma Absolute Return Equity 2.57%
Enhanced Cayman Fund Ltd
Visium Balanced Offshore Fund Ltd 3.01%
ZP Offshore Utility Fund Ltd 5.58%
Protection 4.87%
Conquest Macro Fund Ltd 0.99%
Fortress Convex Asia Fund Ltd 2.01%
TailProtect Ltd 1.87%
Special Investments 1.11%
ALTIN AG 1.39%
Total 126.26%2
ALTIN: Q2 2015 commentary
Following a good start to the year, ALTIN's NAV performed well
during the first two months of the second quarter (+0.34% MTD as
30.04.2015, +0.79% MTD as 31.05.2015) and suffered in June (-1.94%
MTD, estimate) as global financial markets declined dramatically
and volatility increased towards month-end over the escalating
uncertainty over a possible Grexit.
While the months of April and May were relatively benign, June
was a different story. Nonetheless, ALTIN's portfolio outperformed
traditional asset classes over a month that was characterised by a
positive correlation of bonds and equities, as illustrated by the
MSCI World being down -2.5% in June and 10yr bonds in the US and
Germany selling off about 2% on average.
With regards to the ALTIN portfolio, the main performance
drivers for the second quarter were equity-based strategies,
primarily Equity Hedge followed by Event Driven and Relative Value.
Noteworthy detractors for the quarter were Macro and Protection
strategies.
In Equity Hedge, geographical and sector diversification were
beneficial for the quarter, with the main positive contributions
coming from exposure to a Chinese equity specialist and from a
biotech sector specialist. Elsewhere, there were positive
contributions from bottom-up stock pickers across Europe and the
US. Generally speaking short books detracted from performance for
Equity Hedge managers during the second quarter. A large majority
of stock pickers believe that future cash flows are being
discounted inappropriately due to the prevailing low rates and thus
maintain their short exposures in anticipation of a negative
reaction by markets once the Federal Reserve finally decides to
raise rates.
M&A within the healthcare sector remains a meaningful driver
of performance for Event Driven managers. Following the large wave
of tax inversions, all companies that inverted report very low tax
rates and are in a powerful position to continue to make
acquisitions. Additionally, the Supreme Court of the United States
upheld the prevailing law that federal subsidy payments on
federally run exchanges are legal, ending the uncertainty over the
past year and keeping the Affordable Care Act intact. This will
give more visibility to companies and allow them to pursue
strategic M&A activity.
Within Relative Value, multi-strategy funds continue to perform
positively with the bulk of the risk budget allocated to
fundamental and quantitative equity strategies. Healthcare and
technology equities have provided a large opportunity set for
multi-strategy funds in Q2 from both the long and short sides. The
allocation to credit and fixed income remains disappointing in
absolute terms but rather resilient given the higher volatility in
Treasuries. A position with a distressed credit specialist focusing
on Emerging Markets provided a positive stream of returns for the
quarter.
Macro and Protection strategies were the main detractors this
quarter. Discretionary managers posted mixed returns and CTAs were
down across the board as trend following strategies lost on
equities, fixed income and commodities and consequently erased most
of the gains generated in Q1. Essentially, trend following
strategies suffered from the rising correlation between fixed
income and equities. For discretionary managers the sell-off in
stocks was the major detractor as they held long positions in
European, Japanese and US indices. From a currency perspective, the
decline of the USD over the period has also added to the relative
underperformance of macro managers, which were mostly positioned
with long dollar trades. Protection strategies also detracted as
markets didn't sell off violently in a widespread panic and in fact
even rebounded during the quarter, stopping out short equity
positions. Being long USD and long volatility bias also detracted
from the performance of Protection funds.
With regards to individual positions, one of the best performers
for the quarter was a value-biased stock picker based in Hong Kong.
Chinese equities rallied strongly in April following the central
bank lowering reserve requirements and outlining a programme to
improve demand for local government debt. Interestingly, China
A-shares had already rallied strongly in Q1, but what changed in Q2
was the Hong Kong H-shares surge fuelled by a significant increase
in retail investor volume. However, after posting a very strong
performance, Chinese equity indices suffered a sharp correction in
June sparked by concerns of an IPO oversupply and bubble-like
valuations. Initially officials didn't comment, however strong
action towards the end of the month drove a recovery across Chinese
indices. Elsewhere biotechnology has continued to be a strong
contributor, as valuations remain very mixed across the sector with
some companies trading at extremely high valuations while
commercially profitable companies remain relatively cheap for some
stock pickers.
In terms of portfolio activity the portfolio is expected to
remain stable for the foreseeable future as no large reallocations
are planned which would change ALTIN's risk profile. Profits were
taken on some successful long ideas and proceeds invested in tail
protection with a long volatility profile in the US and in Asia.
Additionally, a macro manager with a thematic approach on emerging
markets with the ability to play the zone from the short side was
added. Following the strong rally in biotech a long-biased manager
was replaced with a market neutral healthcare specialist. The
relative liquidity of the portfolio should be beneficial in order
to seize new investment opportunities arise going forward.
Top contributors YTD as of 30.06.2015 (estimated data)
-- Perceptive Life Sciences Offshore Fund Ltd +0.78%
-- Zeal China Fund Limited +0.57%
-- Paulson Enhanced Ltd +0.53%
Top detractors YTD as of 30.06.2015 (estimated data)
-- Two Sigma Compass Enhanced Cayman Fund Ltd -0.61%
-- Civic Capital Currency Offshore Fund Ltd -0.33%
-- Fortress Macro Fund Ltd -0.30%
ALTIN: Portfolio profile to remain stable
For the time being the portfolio is expected to remain fairly
stable and at this stage anticipated hedge fund reallocations
should not dramatically change the profile of the Fund. It is to be
emphasised that a significant portion of the portfolio is liquid
enough to quickly take advantage of new investment opportunities
should they arise during the course of the coming months.
Asset Allocation according to redemption frequency (including
remaining lock-ups)
as at 1 July 2015
Daily 4.46%
Weekly 8.00%
Monthly 45.73%
Quarterly 51.64%
Longer than Quarterly 16.46%
Total 126.26%2ALTIN's gross exposure stands at 126.26%
as at 1 July 2015, vs. 124.12% as 1 April 2015
ALTIN: not affected by redemption issues
ALTIN is a closed-ended and fixed capital fund and as such it is
not faced with redemption requests. This provides the investment
manager with the opportunity to select the best risk/reward
opportunities in the hedge fund universe. Investors can freely buy
and sell ALTIN shares on a daily basis on the London or Swiss stock
exchanges, without the need to redeem at fixed redemption
dates.
For further information, please contact:
Tony Morrongiello - Chief Executive Officer Kinlan Communications
Tel. +41 (0)41 760 62 60 David Hothersall
Tel. +44 (0)20 7638 3435
info@altin.ch davidh@kinlan.net
Note to Editors
About ALTIN AG
ALTIN AG was launched in 1996 and is listed on the SIX Swiss
Exchange as well as on the London Stock Exchange. It ranks among
Switzerland's leading alternative investment companies. Currently,
ALTIN is invested in more than 40 hedge funds representing diverse
investment strategies. Its objective is to generate an absolute
compound annual return in USD terms with lower volatility than
equity markets. Thanks to these characteristics and a low
correlation with equity markets, ALTIN shares provide an ideal
complement to all diversified portfolios.
www.altin.ch
1 Estimated NAV performance as at 30 June 2015
2 ALTIN's gross exposure stands at 126.26% as at 1 July 2015,
vs. 124.12% as 1 April 2015
View source version on businesswire.com:
http://www.businesswire.com/news/home/20150716005047/en/
This information is provided by Business Wire
Altin Reg (LSE:AIA)
Historical Stock Chart
From Dec 2024 to Jan 2025
Altin Reg (LSE:AIA)
Historical Stock Chart
From Jan 2024 to Jan 2025